Drug delivery systems are engineered technologies for the targeted shipping and managed launch of healing dealers. Drug delivery is the strategy or procedure of administering a pharmaceutical compound to accomplish a remedial impact in people or animals. For the treatment of human infections, nasal and aspiratory courses of medication conveyance are increasing expanding significance. These courses give promising other options to parenteral medication conveyance especially for peptide and protein therapeutics. For this reason, a few medication conveyance frameworks have been detailed and are being examined for nasal and aspiratory conveyance. These incorporate cyclodextrins, prodrugs, gels, microspheres, proliposomes and liposomes.
How Big is the Drug Delivery Technology Market?
The Drug Delivery Technology Market is expected to be around US$ 2485 Billion by 2028; Growing at a CAGR of 7.5% in the given forecast period.
The major driving factors of drug delivery technology market are as follows:
Technological advancements and drug innovation
Launching of the new products
Increase in the biologics market
Expanding prevalence of chronic disease
The drug delivery technology market is segmented on the lines of its route of administration, end user and regional. Based on route of administration segmentation it covers pulmonary drug delivery,ocular drug delivery,topical drug delivery,transmucosal drug delivery, oral drug delivery, injectable drug delivery,nasal drug delivery andimplantable drug delivery. Pulmonary drug delivery is further segmented into nebulizers, dry powder inhaler and metered dose inhaler. Ocular drug delivery segmentation contains ocular devices, semi solid and liquid. Under tropical drug delivery it covers transdermal, solid, semi solid and liquid. Transmucosal drug delivery segmentation covers oral and other. Based on oral drug delivery segmentation it covers liquid, solid and semi solid. Under injectable drug delivery segmentation it contains devices and formulations.
The drug delivery technology market is segmented on the lines of its nasal drug delivery like nasal gels, nasal powder, nasal spray and nasal drops. Under implantable drug delivery segmentation it covers passive implantable drug delivery and active implantable drug delivery. Based on end user segmentation it covers diagnostic centers, home care settings, ASCs/ clinics, hospitals and other end users.The drug delivery technology marketis geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for drug delivery technology and related technologies.
2) Analysis of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for drug delivery technology.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for Drug Delivery Technology with the reasons given for variations in the growth of the industry in certain regions.
The report mentions the detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Roche (Switzerland),Pfizer, Inc. (U.S.), Johnson & Johnson Services Inc. (U.S.), Novartis AG (Switzerland), and Bayer AG (Germany). Company profile includes details such as company summary, financial summary,business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Drug delivery technology Market has been segmented as below:
By Route of Administration Analysis
Pulmonary drug delivery
Nebulizers
Dry powder inhaler
Metered dose inhaler
Ocular drug delivery
Ocular devices
Semi solid
Liquid
Topical drug delivery
Transdermal
Solid
Semi solid
Liquid
Transmucosal drug delivery
Oral
Other
Oral drug delivery
Liquid
Solid
Semi solid
Injectable drug delivery
Devices
Formulations
Nasal drug delivery
Nasal gels
Nasal powder
Nasal spray
Nasal drops
Implantable drug delivery
Passive implantable drug delivery
Active implantable drug delivery
By End-user Analysis
Diagnostic centers
Home care settings
ASCs/ Clinics
Hospitals
Other end users
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
Reasons to Buy this Report:
1) Get the most up to date information available on all drug delivery technology in the market globally.
2) Identify growth segments and opportunities in the industry.
3) Report includes decision making on the basis of strong historic and forecast of drug delivery technology data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
Active Pharmaceutical Ingredient (API) Market
Active Pharmaceutical Ingredient/ API Market
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Key Data From Secondary Sources
2.4 Key Data From Primary Sources
2.5 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Topical Drug Delivery: Market Overview
4.2 Drug Delivery Technology Market, By Facility of Use
4.3 Solid Oral Drug Delivery Technology Market, By Dosage Form
4.4 Drug Delivery Technology Market, By Route of Administration
4.5 Geographical Snapshot of the Drug Delivery Technology Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.3 Drivers
5.3.1 Rising Prevalence of Chronic Diseases
5.3.2 Growth in the Biologics Market
5.3.3 Technological Advancement and New Product Launches
5.4 Restraints
5.4.1 Risk of Needlestick Injuries and Side Effects of Drugs
5.4.2 Product Recalls
5.5 Opportunities
5.5.1 Self-Administration and Home Care
5.5.2 Rising Demand for Biosimilars and Generic Drugs
5.5.2.1 Biosimilars
5.5.2.2 Generic Drugs
5.5.3 Focus on Overcoming Unmet Medical Needs
5.5.4 Emerging Markets
5.6 Challenges
5.6.1 Patent Expiry and Patent Cliff
5.6.2 Pricing Pressure
6 Regulatory Scenario
6.1 Introduction
6.2 Drug Approval in the U.S.
6.3 Drug Approval in Europe
7 Drug Delivery Technology Market, By Route of Administration
7.1 Introduction
7.2 Oral Drug Delivery
7.2.1 Solid Oral Drugs
7.2.1.1 Tablets
7.2.1.2 Capsules
7.2.1.3 Powders
7.2.1.4 Pills
7.2.2 Liquid Oral Drugs
7.2.2.1 Solutions
7.2.2.2 Syrups
7.2.3 Semi-Solid Oral Drugs
7.2.3.1 Gels
7.2.3.2 Emulsions
7.2.3.3 Elixirs
7.3 Pulmonary Drug Delivery
7.3.1 Formulations
7.3.2 Devices
7.3.2.1 Metered Dose Inhalers
7.3.2.2 Dry Powder Inhalers
7.3.2.3 Nebulizers
7.3.2.3.1 Jet Nebulizers
7.3.2.3.2 Ultrasonic Nebulizers
7.3.2.3.3 Soft Mist Nebulizers
7.4 Injectable Drug Delivery
7.4.1 Devices
7.4.1.1 Conventional Injection Devices
7.4.1.1.1 By Material
7.4.1.1.2 Glass
7.4.1.1.3 Plastic
7.4.1.1.4 By Product
7.4.1.1.4.1 Fillable Syringes
7.4.1.1.4.2 Prefilled Syringes
7.4.1.1.5 By Usability
7.4.1.1.5.1 Reusable Syringes
7.4.1.1.5.2 Disposable Syringes
7.4.1.2 Self-Injection Devices
7.4.1.2.1 Needle-Free Injectors
7.4.1.2.2 Autoinjectors
7.4.1.2.3 Pen Injectors
7.4.1.2.4 Wearable Injectors
7.4.1.3 Other Injector Devices
7.4.2 Formulations
7.4.2.1 Conventional Drug Delivery
7.4.2.2 Novel Drug Delivery Formulations
7.4.2.3 Long-Acting Injection Formulations
7.5 Ocular Drug Delivery
7.5.1 Formulations
7.5.1.1 Liquid Formulations
7.5.1.1.1 Eye Drops
7.5.1.1.2 Liquid Sprays
7.5.1.2 Semi-Solid Formulations
7.5.1.2.1 Gels
7.5.1.2.2 Eye Ointments
7.5.2 Ocular Devices
7.5.2.1 Drug-Coated Contact Lenses
7.5.2.2 Ocular Inserts
7.6 Nasal Drug Delivery
7.6.1 Nasal Drops
7.6.2 Nasal Sprays
7.6.3 Nasal Powders
7.6.4 Nasal Gels
7.7 Topical Drug Delivery
7.7.1 Formulations
7.7.1.1 Liquid Topical Drug Delivery
7.7.1.1.1 Solutions
7.7.1.1.2 Suspensions
7.7.1.2 Semi-Solid Topical Drug Delivery
7.7.1.2.1 Creams
7.7.1.2.2 Gels
7.7.1.2.3 Ointments
7.7.1.2.4 Pastes
7.7.1.2.5 Lotions
7.7.1.3 Solid Topical Drug Delivery
7.7.1.3.1 Suppositories
7.7.1.3.2 Powders
7.7.2 Devices (Transdermal Drug Delivery)
7.7.2.1 Transdermal Patches
7.7.2.2 Transdermal Gels
7.8 Implantable Drug Delivery
7.8.1 Active Implantable Drug Delivery
7.8.2 Passive Implantable Drug Delivery
7.9 Transmucosal Drug Delivery
7.9.1 Oral Transmucosal Drug Delivery
7.9.1.1 Buccal Drug Delivery
7.9.1.2 Sublingual Drug Delivery
7.9.2 Other Transmucosal Drug Delivery
7.9.2.1 Rectal Transmucosal Drug Delivery
7.9.2.2 Vaginal Transmucosal Drug Delivery
8 Drug Delivery Technology Market, By Facility of User
8.1 Introduction
8.2 Hospitals
8.3 Ambulatory Surgical Centers/Clinics
8.4 Home Care Settings
8.5 Diagnostic Centers
8.6 Other Facilities of Use
9 Drug Delivery Technology Market, By Region
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Rest of Europe (RoE)
9.4 Asia
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest of Asia
9.5 Rest of the World
10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Situations & Trends
10.3.1 Product Launches & Approvals
10.3.2 Partnerships, Agreements, and Collaborations
10.3.3 Acquisitions, Mergers, and Joint Ventures
10.3.4 Expansions
11 Company Profiles
11.1 Introduction
11.2 Johnson & Johnson Services, Inc.
11.3 Novartis AG
11.4 F. Hoffmann-La Roche Ltd.
11.5 Pfizer, Inc.
11.6 Bayer AG
11.7 Antares Pharma, Inc.
11.8 Becton, Dickinson and Company
11.9 Glaxosmithkline PLC
11.10 3M
11.11 Merck & Co., Inc.
11.12 Sanofi
The Drug delivery technology Market has been segmented as below:
By Route of Administration Analysis
Pulmonary drug delivery
Nebulizers
Dry powder inhaler
Metered dose inhaler
Ocular drug delivery
Ocular devices
Semi solid
Liquid
Topical drug delivery
Transdermal
Solid
Semi solid
Liquid
Transmucosal drug delivery
Oral
Other
Oral drug delivery
Liquid
Solid
Semi solid
Injectable drug delivery
Devices
Formulations
Nasal drug delivery
Nasal gels
Nasal powder
Nasal spray
Nasal drops
Implantable drug delivery
Passive implantable drug delivery
Active implantable drug delivery
By End-user Analysis
Diagnostic centers
Home care settings
ASCs/ Clinics
Hospitals
Other end users
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
SUBSCRIBE TO OUR NEWSLETTERS
